STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. VTVT
  4. [EFFECT] vTv Therapeutics Inc. SEC Filing

[EFFECT] vTv Therapeutics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 24, 2025 4:00 P.M.
Form: S-3
CIK: 0001641489
Company Name: vTv Therapeutics Inc.
File Number: 333-290709

Source: View Original Filing on SEC EDGAR

Stock VTVT logo
Vtv Therapeutics

NASDAQ:VTVT

VTVT Rankings

#4800 Ranked by Market Cap
N/A Ranked by Dividends
#54 Top Loser

VTVT Latest News

Nov 6, 2025
vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 9, 2025
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
Sep 15, 2025
vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting
Sep 3, 2025
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
Sep 3, 2025
vTv Therapeutics to Participate in Upcoming September Investor Conferences

VTVT Latest SEC Filings

Nov 6, 2025
[8-K] vTv Therapeutics Inc. Reports Material Event
Nov 6, 2025
[10-Q] vTv Therapeutics Inc. Quarterly Earnings Report
Oct 3, 2025
[S-3] vTv Therapeutics Inc. Shelf Registration Statement
Sep 25, 2025
[SCHEDULE 13D/A] vTv Therapeutics Inc. SEC Filing
Sep 25, 2025
[Form 4] vTv Therapeutics Inc. Insider Trading Activity

VTVT Stock Data

116.41M
3.01M
35.51%
39.63%
0.56%
Biotechnology
Pharmaceutical Preparations
Link
United States
HIGH POINT